Rivaroxaban Zentiva 20 mg Filmtabletten Deutschland - Deutsch - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

rivaroxaban zentiva 20 mg filmtabletten

zentiva pharma gmbh (8075753) - rivaroxaban - filmtablette - 20 mg - rivaroxaban (32254) 20 milligramm

Rivaroxaban Zentiva 20 mg Hartkapseln Deutschland - Deutsch - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

rivaroxaban zentiva 20 mg hartkapseln

zentiva pharma gmbh (8075753) - hartkapsel - 20 mg

Rivaroxaban Zentiva 2,5 mg Hartkapseln Deutschland - Deutsch - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

rivaroxaban zentiva 2,5 mg hartkapseln

zentiva pharma gmbh (8075753) - rivaroxaban - hartkapsel - 2,5 mg - rivaroxaban (32254) 2,5 milligramm

Rivaroxaban Zentiva 15 mg Filmtabletten Deutschland - Deutsch - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

rivaroxaban zentiva 15 mg filmtabletten

zentiva pharma gmbh (8075753) - rivaroxaban - filmtablette - rivaroxaban (32254) 15 milligramm

Rivaroxaban Zentiva 10 mg Filmtabletten Deutschland - Deutsch - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

rivaroxaban zentiva 10 mg filmtabletten

zentiva pharma gmbh (8075753) - rivaroxaban - filmtablette - rivaroxaban (32254) 10 milligramm

Rivaroxaban Zentiva 2,5 mg Filmtabletten Deutschland - Deutsch - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

rivaroxaban zentiva 2,5 mg filmtabletten

zentiva pharma gmbh (8075753) - rivaroxaban - filmtablette - 2,5 mg - rivaroxaban (32254) 2,5 milligramm

Rivaroxaban Zentiva 15 mg Hartkapseln Deutschland - Deutsch - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

rivaroxaban zentiva 15 mg hartkapseln

zentiva pharma gmbh (8075753) - hartkapsel - 15 mg

Rivaroxaban beta 20 mg Hartkapseln Deutschland - Deutsch - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

rivaroxaban beta 20 mg hartkapseln

betapharm arzneimittel gmbh (3364323) - hartkapsel - 20 mg rivaroxaban

Rivaroxaban Zentiva 10 mg Hartkapseln Deutschland - Deutsch - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

rivaroxaban zentiva 10 mg hartkapseln

zentiva pharma gmbh (8075753) - hartkapsel - 10 mg

Rivaroxaban Viatris (previously Rivaroxaban Mylan) Europäische Union - Deutsch - EMA (European Medicines Agency)

rivaroxaban viatris (previously rivaroxaban mylan)

mylan ireland limited - rivaroxaban - venous thromboembolism; pulmonary embolism; acute coronary syndrome; stroke; coronary artery disease; peripheral arterial disease; atrial fibrillation - antithrombotische mittel - rivaroxaban mylan co-administered with acetylsalicylic acid (asa) alone or with asa plus clopidogrel or ticlopidine, is indicated for the prevention of atherothrombotic events in adult patients after an acute coronary syndrome (acs) with elevated cardiac biomarkers.  rivaroxaban mylan co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in adult patients with coronary artery disease (cad) or symptomatic peripheral artery disease (pad) at high risk of ischaemic events.  ------prevention of venous thromboembolism (vte) in adult patients undergoing elective hip or knee replacement surgery.  treatment of deep vein thrombosis (dvt) and pulmonary embolism (pe), and prevention of recurrent dvt and pe in adults. -------adults prevention of stroke and systemic embolism in adult   patients with non-valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke or transient ischaemic attack. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing from 30 kg to 50 kg after at least 5 days of initial parenteral anticoagulation treatment. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing more than 50 kg after at least 5 days of initial parenteral anticoagulation treatment.